Got $5,000? 2 Growth Stocks Powering the Next Phase of the Space Economy.

Rocket Lab's Q2 2026 revenue rose 62% year over year to $234 million, while Planet Labs' revenue increased 58% to $116.1 million; both businesses are expanding satellite-related operations and government contracts. Rocket Lab's proposed Iridium acquisition could add a services business but involves share dilution and debt, while its Neutron launch has been postponed to 2027. Planet Labs reported 98% recurring annual contract value under its stated definition and 109% net dollar retention, but its Q3 revenue outlook is $101 million to $105 million and capital spending, convertible notes, and potential share issuance pose risks. Both stocks trade at substantial revenue multiples, leaving execution and investment returns uncertain.

Analysis

The key underwriting distinction is what each company must spend to convert demand into durable per-share cash flow. For Rocket Lab (RKLB), Iridium would add a service layer that could make revenue less dependent on hardware deliveries, but the equity-funded purchase raises the bar: acquired cash generation must outweigh dilution, debt, and integration costs before the deal creates value per share. The proposed Space Force work is not equivalent to firm, near-term Neutron revenue; options and launch timing leave execution risk concentrated in one program. A further Neutron delay could therefore hit both investor confidence and contract timing.

Planet Labs (PL) offers a different path: reuse of existing imagery can support attractive incremental economics, while dedicated government capacity may pull the business toward more capital-intensive, bespoke delivery. Do not extrapolate its reported recurring-contract metric to all revenue; satellite-service work may bring lumpier recognition and capex. The Swedish handover also makes the next-quarter sequential decline a weak standalone demand signal, but contract renewals, expansion, and cash conversion matter more than headline growth.

Contrarian point: PL's lower sales multiple than RKLB does not make it automatically cheap, and RKLB's backlog does not guarantee attractive returns on newly issued shares. The market may underweight dilution and contract mix for both. Over 1–3 months, watch Neutron schedule updates, acquisition terms/closing, PL guidance and cash use. Over 6–18 months, the test is whether service and data revenues scale without persistent equity funding. Potential substitution and procurement competition from BlackSky and other Earth-observation providers is a risk to PL; SpaceX remains a private launch competitor, limiting direct public-market hedges.

Key Decisions for Investors

• Prefer PL over RKLB for incremental exposure, but size it as a high-volatility growth position rather than treating the lower revenue multiple as a valuation floor. Reassess if contract expansion weakens or capex and cash burn rise without improving cash conversion.
• Keep RKLB exposure modest pending clearer acquisition economics and Neutron milestones. Verify final consideration, assumed debt, share count, closing conditions, and the proportion of backlog tied to firm awards versus options before underwriting accretion.
• Avoid a mechanical long-PL/short-RKLB pair: their business models and catalysts differ, and the valuation gap alone is not a hedge. Revisit only if relative performance diverges from evidence on renewals, margins, dilution, and execution.
• For PL, monitor the next report for ACV/renewal trends, satellite-services contribution, capex versus the stated plan, and equity issuance. A sustained deterioration in retention or funding needs would falsify the data-monetization thesis; a sequential revenue dip alone would not.